151 related articles for article (PubMed ID: 26512539)
1. Pharmacokinetics and bioavailability of orbifloxacin oral suspension in New Zealand White rabbits (Oryctolagus cuniculus).
Watson MK; Wittenburg LA; Bui CT; Jarosz KA; Gustafson DL; Johnston MS
Am J Vet Res; 2015 Nov; 76(11):946-51. PubMed ID: 26512539
[TBL] [Abstract][Full Text] [Related]
2. The pharmacokinetics of orbifloxacin in the horse following oral and intravenous administration.
Davis JL; Papich MG; Weingarten A
J Vet Pharmacol Ther; 2006 Jun; 29(3):191-7. PubMed ID: 16669863
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic-pharmacodynamic integration of orbifloxacin in Japanese quail (Coturnix japonica) following oral and intravenous administration.
Hawkins MG; Taylor IT; Byrne BA; Armstrong RD; Tell LA
J Vet Pharmacol Ther; 2011 Aug; 34(4):350-8. PubMed ID: 20950349
[TBL] [Abstract][Full Text] [Related]
4. Ciprofloxacin pharmacokinetics and oral absorption of generic ciprofloxacin tablets in dogs.
Papich MG
Am J Vet Res; 2012 Jul; 73(7):1085-91. PubMed ID: 22738062
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of meloxicam administered orally to rabbits (Oryctolagus cuniculus) for 29 days.
Delk KW; Carpenter JW; KuKanich B; Nietfeld JC; Kohles M
Am J Vet Res; 2014 Feb; 75(2):195-9. PubMed ID: 24471756
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic-pharmacodynamic integration of orbifloxacin in rabbits after intravenous, subcutaneous and intramuscular administration.
Marín P; Fernández-Varón E; Escudero E; Vancraeynest D; Cárceles CM
J Vet Pharmacol Ther; 2008 Feb; 31(1):77-82. PubMed ID: 18177323
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of orbifloxacin in crucian carp (Carassius auratus) after intravenous and intramuscular administration.
Yang F; Yang F; Wang G; Shi W; Kong T; Yang P; Bai D; Zhou B
J Vet Pharmacol Ther; 2018 Aug; 41(4):599-604. PubMed ID: 29465160
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of mavacoxib in New Zealand White rabbits (Oryctolagus cuniculus).
Wilson SE; Carpenter JW; Gardhouse S; KuKanich B
Am J Vet Res; 2023 May; 84(5):. PubMed ID: 36990439
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of meloxicam in rabbits after oral administration of single and multiple doses.
Fredholm DV; Carpenter JW; KuKanich B; Kohles M
Am J Vet Res; 2013 Apr; 74(4):636-41. PubMed ID: 23531074
[TBL] [Abstract][Full Text] [Related]
10. Single- and multiple-dose pharmacokinetics of marbofloxacin after oral administration to rabbits.
Carpenter JW; Pollock CG; Koch DE; Hunter RP
Am J Vet Res; 2009 Apr; 70(4):522-6. PubMed ID: 19335109
[TBL] [Abstract][Full Text] [Related]
11. Single and multiple-dose pharmacokinetics of meloxicam after oral administration to the rabbit (Oryctolagus cuniculus).
Carpenter JW; Pollock CG; Koch DE; Hunter RP
J Zoo Wildl Med; 2009 Dec; 40(4):601-6. PubMed ID: 20063804
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of orbifloxacin and its concentration in body fluids and in endometrial tissues of mares.
Haines GR; Brown MP; Gronwall RR; Merritt KA; Baltzley LK
Can J Vet Res; 2001 Jul; 65(3):181-7. PubMed ID: 11480524
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of maropitant citrate in New Zealand White rabbits (
Ozawa SM; Hawkins MG; Drazenovich TL; Kass PH; Knych HK
Am J Vet Res; 2019 Oct; 80(10):963-968. PubMed ID: 31556710
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and pharmacokinetic/pharmacodynamic integration of orbifloxacin in Korean Hanwoo cattle.
Elias G; Lee JS; Hwang MH; Park YS; Cho KH; Kim YH; Park SC
J Vet Pharmacol Ther; 2009 Jun; 32(3):219-28. PubMed ID: 19646085
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and safety of ceftiofur crystalline free acid in New Zealand White rabbits (Oryctolagus cuniculus).
Gardhouse S; Guzman DS; Cox S; Kass PH; Drazenovich TL; Byrne BA; Hawkins MG
Am J Vet Res; 2017 Jul; 78(7):796-803. PubMed ID: 28650231
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and milk penetration of orbifloxacin after intravenous, subcutaneous, and intramuscular administration to lactating goats.
Marín P; Escudero E; Fernández-Varón E; Cárceles CM
J Dairy Sci; 2007 Sep; 90(9):4219-25. PubMed ID: 17699040
[TBL] [Abstract][Full Text] [Related]
17. Development of a multiroute physiologically based pharmacokinetic model for orbifloxacin in rabbits.
Yang F; Yang F; Shi W; Si H; Kong T; Wang G; Zhang J
J Vet Pharmacol Ther; 2018 Aug; 41(4):622-631. PubMed ID: 29457247
[TBL] [Abstract][Full Text] [Related]
18. Comparative pharmacokinetics of orbifloxacin in healthy and Pasteurella multocida infected ducks.
Tohamy MA
Br Poult Sci; 2011 Oct; 52(5):639-44. PubMed ID: 22029792
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and milk distribution characteristics of orbifloxacin following intravenous and intramuscular injection in lactating ewes.
Goudah A; Cho HJ; Shin HC; Shim JH; Regmi NL; Shimoda M; Abd El-Aty AM
J Vet Pharmacol Ther; 2009 Aug; 32(4):338-44. PubMed ID: 19614838
[TBL] [Abstract][Full Text] [Related]
20. Effects of lidocaine administration via continuous rate infusion on the minimum alveolar concentration of isoflurane in New Zealand White rabbits (Oryctolagus cuniculus).
Schnellbacher RW; Carpenter JW; Mason DE; KuKanich B; Beaufrère H; Boysen C
Am J Vet Res; 2013 Nov; 74(11):1377-84. PubMed ID: 24168301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
